Alexander Yevzlin, MD
Nephrology · Ann Arbor, MINPI 1962463315
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,024,544 of the $1,087,684 with a category attached, or 94.2%. 11 manufacturers reported payments, led by Phraxis, Inc. at 56.4% of the total. Among nephrology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $7349.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Phraxis, Inc.$614K
- Sonavex, Inc.$281K
- AV Medical Technologies Ltd.$138K
- Covidien LP$42K
- Bard Peripheral Vascular, Inc.$9K
- Medtronic$3K
- plus $178 from 5 others
Across 12 payments — averaging $9650.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$99K
- Venturemed Group, Inc.$12K
- C. R. Bard, Inc. & Subsidiaries$5K
Across 5 payments — averaging $22,379 each. An ownership or investment interest held by the physician or an immediate family member.
- Phraxis, Inc.$112K
What the payments were for
- Royalty or licence$3030%
- Consulting fees$1,024,54494%
- Speaking & faculty fees$16,8002%
- Travel & lodging$39,7194%
- Food & beverage$6,3181%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Phraxis, Inc. | 27 | $613,821 |
| Sonavex, Inc. | 15 | $281,347 |
| AV Medical Technologies Ltd. | 15 | $137,983 |
| Covidien LP | 38 | $42,446 |
| Bard Peripheral Vascular, Inc. | 28 | $9,275 |
| Medtronic | 20 | $2,634 |
| Fresenius USA Marketing, Inc. | 1 | $98 |
| Arjo Inc. | 1 | $28 |
| Mozarc Medical US LLC | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Venturemed Group, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InterGraft Venous Anastomotic Connector$177,503
- Chameleon$154,594
- EchoMark$71,089
- EchoSure$71,089
- Venous InterGraft$51,900
- Argyle$18,897
- Palindrome$7,565
- ELLIPSYS VASCULAR ACCESS SYSTEM$911
- WAVELINQ$441
- Pristine$303
- InterGraft Venous Anastomonic Connector$266
How this compares
$1,087,684 in reported general payments places this provider in the 95th percentile of 325 nephrology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $338 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $329 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Ann Arbor
- Laura MarianiAnn Arbor$150K
- Matthias KretzlerAnn Arbor$70K
- Lenar YessayanAnn Arbor$40K
- Bruce RobinsonAnn Arbor$38K
- Karthik RamaniAnn Arbor$27K
- Rajiv SaranAnn Arbor$23K
- Panduranga RaoAnn Arbor$20K
- Andrea OliverioAnn Arbor$15K
- Abhijit NaikAnn Arbor$10K
- Akinlolu OjoAnn Arbor$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.